Overdiagnosis: How our compulsion for diagnosis may be harming children

Pediatrics

Volumn 134, Issue 5, 2014, Pages 1013-1023

  Coon, Eric R ^a   Quinonez, Ricardo A ^b   Moyer, Virginia A ^c   Schroeder, Alan R ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c AMERICAN BOARD OF PEDIATRICS   (United States)

^d SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

Medical education; Public health

Indexed keywords

ASPIRATION; ATTENTION DEFICIT DISORDER; BACTEREMIA; BRONCHIOLITIS; CHILD; CHOLELITHIASIS; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FINANCIAL MANAGEMENT; FOOD ALLERGY; GASTROESOPHAGEAL REFLUX; HEALTH CARE INDUSTRY; HEALTH CARE SYSTEM; HUMAN; HYPERBILIRUBINEMIA; HYPERCHOLESTEROLEMIA; HYPOXEMIA; INCIDENCE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; MORBIDITY; MORTALITY; NEUROBLASTOMA; OVERDIAGNOSIS; PATIENT HARM; PEDIATRICS; PERSONNEL MANAGEMENT; PHYSICAL CAPACITY; PHYSICIAN ATTITUDE; PSYCHOLOGICAL ASPECT; PUBLICATION; REVIEW; RISK ASSESSMENT; SKULL FRACTURE; SLEEP DISORDERED BREATHING; URINARY TRACT INFECTION; VESICOURETERAL REFLUX; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CLINICAL COMPETENCE; FOOD HYPERSENSITIVITY; PREVENTION AND CONTROL; STANDARDS; TRENDS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CLINICAL COMPETENCE; DIAGNOSTIC ERRORS; FOOD HYPERSENSITIVITY; HUMANS; PEDIATRICS;

EID: 84908892105     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1778     Document Type: Review

References (113)

1. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366
2. Schilling FH, Spix C, Berthold F, et al. Neuroblastoma screening at one year of age. N Engl J Med. 2002;346(14):1047-1053
3. Spix C, Michaelis J, Berthold F, Erttmann R, Sander J, Schilling FH. Lead-time and overdiagnosis estimation in neuroblastoma screening. Stat Med. 2003;22(18):2877-2892
4. Woods WG, Gao RN, Shuster JJ, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med. 2002;346(14):1041-1046
5. National Cancer Institute. Surveillance, epidemiology, and end results program. Available at: http://seer.cancer.gov
6. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol. 1996;30(2):138-144
7. Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;1:CD004720
8. Andriole GL, Crawford ED, Grubb RL III, et al; PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310-1319
9. Jaffe DM, Tanz RR, Davis AT, Henretig F, Fleisher G. Antibiotic administration to treat possible occult bacteremia in febrile children. N Engl J Med. 1987;317(19):1175-1180
10. Newman TB, Bernzweig JA, Takayama JI, Finch SA, Wasserman RC, Pantell RH. Urine testing and urinary tract infections in febrile infants seen in office settings: the Pediatric Research in Office Settings' Febrile Infant Study. Arch Pediatr Adolesc Med. 2002;156(1):44-54
11. Waisbren SE, Albers S, Amato S, et al. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA. 2003;290(19):2564-2572
12. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-2167
13. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis. 2001;183(1):16-22
14. Brooks JC, Fisher-Owens SA, Wu YW, Strauss DJ, Newman TB. Evidence suggests there was not a "resurgence" of kernicterus in the 1990s. Pediatrics. 2011;127(4):672-679
15. Welch HG, Schwartz L, Woloshin S. Overdiagnosed: Making People Sick in the Pursuit of Health. Boston, MA: Beacon Press; 2011
16. Preventing Overdiagnosis Conference. Available at: www.preventingoverdiagnosis.net/
17. Moynihan R, Glasziou P, Woloshin S, Schwartz L, Santa J, Godlee F. Winding back the harms of too much medicine. BMJ. 2013;346:f1271
18. Newman TB, Kuzniewicz MW, Liljestrand P, Wi S, McCulloch C, Escobar GJ. Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines. Pediatrics. 2009;123(5):1352-1359
19. US Preventive Services Task Force. Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: US Preventive Services Task Force recommendation statement. Pediatrics. 2009;124(4):1172-1177
20. Suresh GK, Clark RE. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants. Pediatrics. 2004;114(4):917-924
21. Podvin D, Kuehn CM, Mueller BA, Williams M. Maternal and birth characteristics in relation to childhood leukaemia. Paediatr Perinat Epidemiol. 2006;20(4):312-322
22. Wickremasinghe AC, Grimes B, McCulloch CE, Newman TB. Association between neonatal phototherapy and admissions for infantile cancer. Paper presented at: Pediatric Academic Societies, platform presentation; 2014; Vancouver, BC
23. Hoffman RM, Lewis CL, Pignone MP, et al Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making. 2010;30(5 suppl):53s-64s
24. Mold JW, Stein HF. The cascade effect in the clinical care of patients. N Engl J Med. 1986;314(8):512-514
25. Harris RP, Sheridan SL, Lewis CL, et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med. 2014;174(2):281-285
26. Nuchtern JG, London WB, Barnewolt CE, et al. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study. Ann Surg. 2012;256(4):573-580
27. Roman HK, Chang PW, Schroeder AR. Diagnosis and management of bacteremic urinary tract infection in infants. Hosp Pediatr. In press
28. Jumani K, Advani S, Reich NG, Gosey L, Milstone AM. Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr. 2013;167(5):429-435
29. Scherer LD, Zikmund-Fisher BJ, Fagerlin A, Tarini BA. Influence of "GERD" label on parents' decision to medicate infants. Pediatrics. 2013;131(5):839-845
30. Green M, Solnit AJ. Reactions to the threatened loss of a child: a vulnerable child syndrome. Pediatric management of the dying child, part III. Pediatrics. 1964;34:58-66
31. Bergman AB, Stamm SJ. The morbidity of cardiac nondisease in schoolchildren. N Engl J Med. 1967;276(18):1008-1013
32. Forsyth BW, Canny PF. Perceptions of vulnerability 3 1/2 years after problems of feeding and crying behavior in early infancy. Pediatrics. 1991;88(4):757-763
33. Usatin D, Liljestrand P, Kuzniewicz MW, Escobar GJ, Newman TB. Effect of neonatal jaundice and phototherapy on the frequency of first-year outpatient visits. Pediatrics. 2010;125(4):729-734
34. Kemper K, Forsyth B, McCarthy P. Jaundice, terminating breast-feeding, and the vulnerable child. Pediatrics. 1989;84(5):773-778
35. Shemesh E, Annunziato RA, Ambrose MA, et al. Child and parental reports of bullying in a consecutive sample of children with food allergy. Pediatrics. 2013;131(1). Available at: www.pediatrics.org/cgi/content/full/131/1/e10
36. Gupta RS, Springston EE, Warrier MR, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics. 2011;128(1). Available at: www.pediatrics.org/cgi/content/full/128/1/e9
37. Food Allergy Research & Education. Food allergy bullying: it 's not a joke. 2014; Available at: www.foodallergy.org/its-not-a-joke#.Ur2nRPRDt8E
38. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513-1516
39. Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics. 2006;118(6):2418-2423
40. Birnbaum HG, Kessler RC, Lowe SW, et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin. 2005;21(2):195-206
41. Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med. 2012;156(5):340-349
42. Merrill JM, Lorimor RJ, Thornby JI, Vallbona C. Reliance on high technology among senior medical students. Am J Med Sci. 1998;315(1):35-39
43. van der Weijden T, van Bokhoven MA, Dinant GJ, van Hasselt CM, Grol RP. Understanding laboratory testing in diagnostic uncertainty: a qualitative study in general practice. Br J Gen Pract. 2002;52(485):974-980
44. Lysdahl KB, Hofmann BM. What causes increasing and unnecessary use of radiological investigations? A survey of radiologists' perceptions. BMC Health Serv Res. 2009;9:155
45. Natale JE, Joseph JG, Rogers AJ, et al; PECARN (Pediatric Emergency Care Applied Research Network). Cranial computed tomography use among children with minor blunt head trauma: association with race/ethnicity. Arch Pediatr Adolesc Med. 2012;166(8):732-737
46. Nevalainen M, Kuikka L, Sjoberg L, Eriksson J, Pitkala K. Tolerance of uncertainty and fears of making mistakes among fifth-year medical students. Fam Med. 2012;44(4):240-246
47. Samadian S, Farhat A. Problem based learning, litigation, and EWTD contribute to too much medicine. BMJ. 2013;347:f4790
48. Woodward C, Ferrier B, Goldsmith C, Cohen M. Billing patterns of general practitioners and family physicians in Ontario: a comparison of graduates of McMaster Medical School with graduates of other Ontario medical schools. In: Research in Medical Education: Proceedings of the Annual Conference. Conference on Research in Medical Education. 1988;27:276-281
49. Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA. 2008;299(23):2789-2791
50. Wallace E, Lowry J, Smith SM, Fahey T. The epidemiology of malpractice claims in primary care: a systematic review. BMJ Open. 2013;3(7)
51. Bishop TF, Federman AD, Keyhani S. Physicians' views on defensive medicine: a national survey. Arch Intern Med. 2010;170(12):1081-1083
52. Sirovich BE, Woloshin S, Schwartz LM. Too little? Too much? Primary care physicians' views on US health care: a brief report. Arch Intern Med. 2011;171(17):1582-1585
53. Sloan FA, Shadle JH. Is there empirical evidence for "defensive medicine "? A reassessment. J Health Econ. 2009;28(2):481-491
54. The Dartmouth Atlas Project. Supply-sensitive care. January 15, 2007. Available at: www.dartmouthatlas.org/downloads/reports/supply-sensitive.pdf
55. Mangione-Smith R, DeCristofaro AH, Setodji CM, et al. The quality of ambulatory care delivered to children in the United States. N Engl J Med. 2007;357(15):1515-1523
56. Stang AS, Straus SE, Crotts J, Johnson DW, Guttmann A. Quality indicators for high acuity pediatric conditions. Pediatrics. 2013;132(4):752-762
57. Kale MS, Bishop TF, Federman AD, Keyhani S. Trends in the overuse of ambulatory health care services in the United States. JAMA Intern Med. 2013;173(2):142-148
58. Bosanquet D, Cho J, Williams N, Gower D, Thomas KG, Lewis M. Requesting radiological investigations: do junior doctors know their patients? A cross-sectional survey. JRSM Short Rep. 2013;4(1):3
59. Rogg JG, Rubin JT, Hansen P, Liu SW. The frequency and cost of redundant laboratory testing for transferred ED patients. Am J Emerg Med. 2013;31(7):1121-1123
60. Moynihan R, Henry D. The fight against disease mongering: generating knowledge for action. PLoS Med. 2006;3(4):e191
61. Schwartz LM, Woloshin S. Changing disease definitions: implications for disease prevalence. Analysis of the Third National Health and Nutrition Examination Survey, 1988-1994. Eff Clin Pract. 1999;2(2):76-85
62. Ricks D, Rabin R. Cholesterol guidelines: drug panelist 's links under fire. Newsday, July 15, 2004
63. Moynihan RN, Cooke GP, Doust JA, Bero L, Hill S, Glasziou PP. Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med. 2013;10(8):e1001500
64. Wolraich M, Brown L, Brown RT, et al; Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attentiondeficit/ hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007-1022
65. Schwarz A. Thousands of toddlers are medicated for A.D.H.D., report finds, raising worries. The New York Times, May 16, 2014
66. Friedman RA. Grief, depression, and the DSM-5. N Engl J Med. 2012;366(20):1855-1857
67. Ventola CL. Direct-to-consumer pharmaceutical advertising: therapeutic or toxic? P T. 2011;36(10):669-684
68. Mintzes B. Should patient groups accept money from drug companies? No. BMJ. 2007;334(7600):935
69. Harris G. Drug makers are advocacy group's biggest donors. The New York Times, October 21, 2009
70. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78
71. Gates TJ. Screening for cancer: evaluating the evidence. Am Fam Physician. 2001;63(3):513-522
72. American Academy of Pediatrics. Ten things physicians and patients should question. Available at: www.choosingwisely.org/doctor-patient-lists/american-academy-ofpediatrics/
73. Quinonez RA, Garber MD, Schroeder AR, et al Choosing wisely in pediatric hospital medicine: five opportunities for improved healthcare value. J Hosp Med. 2013;8(9):479-485
74. US Preventive Services Task Force. Section 3: topic work plan development. Available at: www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual3.htm
75. Wegwarth O, Gigerenzer G. Less is more: overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med. 2013;173(22):2086-2087
76. Stacey D, Légaré F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431
77. Doust J. Diagnosis in general practice. Using probabilistic reasoning. BMJ. 2009;339:b3823
78. University of Colorado School of Medicine. Welcome to the Do No Harm Project. Available at: www.ucdenver.edu/academics/colleges/medicalschool/departments/medicine/GIM/education/DoNoHarmProject/Pages/Welcome.aspx
79. Batstra L, Frances A. Holding the line against diagnostic inflation in psychiatry. Psychother Psychosom. 2012;81(1):5-10
80. Khoshoo V, Edell D. Previously healthy infants may have increased risk of aspiration during respiratory syncytial viral bronchiolitis. Pediatrics. 1999;104(6):1389-1390
81. Sheikh S, Allen E, Shell R, et al. Chronic aspiration without gastroesophageal reflux as a cause of chronic respiratory symptoms in neurologically normal infants. Chest. 2001;120(4):1190-1195
82. Barnhart DC, Hall M, Mahant S, et al. Effectiveness of fundoplication at the time of gastrostomy in infants with neurological impairment. JAMA Pediatr. 2013;167(10):911-918
83. Elder TE. The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. J Health Econ. 2010;29(5):641-656
84. Morrow RL, Garland EJ, Wright JM, Maclure M, Taylor S, Dormuth CR. Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ. 2012;184(7):755-762
85. Frances A, Batstra L. Why so many epidemics of childhood mental disorder? J Dev Behav Pediatr. 2013;34(4):291-292
86. Bogue CO, Murphy AJ, Gerstle JT, Moineddin R, Daneman A. Risk factors, complications, and outcomes of gallstones in children: a single-center review. J Pediatr Gastroenterol Nutr. 2010;50(3):303-308
87. Sicherer SH, Wood RA; American Academy of Pediatrics Section on Allergy and Immunology. Allergy testing in childhood: using allergen-specific IgE tests. Pediatrics. 2012;129(1):193-197
88. Liu AH, Jaramillo R, Sicherer SH, et al National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allerg Clin Immunol. 2010;126(4):798-806. e713
89. Nelson SP, Chen EH, Syniar GM, Christoffel KK; Pediatric Practice Research Group. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Arch Pediatr Adolesc Med. 1997;151(6):569-572
90. Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics. 2002;109(6):1061-1067
91. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154(4):514-520. e514
92. Nelson SP, Kothari S, Wu EQ, Beaulieu N, McHale JM, Dabbous OH. Pediatric gastroesophageal reflux disease and acidrelated conditions: trends in incidence of diagnosis and acid suppression therapy. J Med Econ. 2009;12(4):348-355
93. Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45(4):421-427
94. Kuzniewicz MW, Escobar GJ, Newman TB. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Pediatrics. 2009;124(4):1031-1039
95. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117(5). Available at: www.pediatrics.org/cgi/content/full/117/5/e855
96. Psaty BM, Rivara FP. Universal screening and drug treatment of dyslipidemia in children and adolescents. JAMA. 2012;307(3):257-258
97. Gillman MW, Daniels SR. Is universal pediatric lipid screening justified? JAMA. 2012;307(3):259-260
98. Newman TB, Pletcher MJ, Hulley SB. Overly aggressive new guidelines for lipid screening in children: evidence of a broken process. Pediatrics. 2012;130(2):349-352
99. Schroeder AR, Redberg RF. Cholesterol screening and management in children and young adults should start early - NO! Clin Cardiol. 2012;35(11):665-668
100. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282(15):1440-1446
101. Mallory MD, Shay DK, Garrett J, Bordley WC. Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. Pediatrics. 2003;111(1). Available at: www.pediatrics.org/cgi/content/full/111/1/e45
102. Schroeder AR, Marmor AK, Pantell RH, Newman TB. Impact of pulse oximetry and oxygen therapy on length of stay in bronchiolitis hospitalizations. Arch Pediatr Adolesc Med. 2004;158(6):527-530
103. Unger S, Cunningham S. Effect of oxygen supplementation on length of stay for infants hospitalized with acute viral bronchiolitis. Pediatrics. 2008;121(3):470-475
104. Andresen BS, Dobrowolski SF, O'Reilly L, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet. 2001;68(6):1408-1418
105. Hero B, Simon T, Spitz R, et al. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol. 2008;26(9):1504-1510
106. Marcus CL, Moore RH, Rosen CL, et al; Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368(25):2366-2376
107. Goodman DC, Challener GJ. Tonsillectomy: a procedure in search of evidence. J Pediatr. 2012;160(5):716-718
108. Erickson BK, Larson DR, St Sauver JL, Meverden RA, Orvidas LJ. Changes in incidence and indications of tonsillectomy and adenotonsillectomy, 1970-2005. Otolaryngol Head Neck Surg. 2009;140(6):894-901
109. Mannix R, Monuteaux MC, Schutzman SA, Meehan WP III, Nigrovic LE, Neuman MI. Isolated skull fractures: trends in management in US pediatric emergency departments. Ann Emerg Med. 2013;62(4):327-331
110. Rollins MD, Barnhart DC, Greenberg RA, et al. Neurologically intact children with an isolated skull fracture may be safely discharged after brief observation. J Pediatr Surg. 2011;46(7):1342-1346
111. Greenes DS, Schutzman SA. Infants with isolated skull fracture: what are their clinical characteristics, and do they require hospitalization? Ann Emerg Med. 1997;30(3):253-259
112. Jodal U, Smellie JM, Lax H, Hoyer PF. Tenyear results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatr Nephrol. 2006;21(6):785-792
113. Hoberman A, Greenfield SP, Mattoo TK, et al; RIVUR Trial Investigators. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370(25):2367-2376